A Comparative Study of TG103 Produced by Two Manufacturing Processes in Chinese Healthy Male Subjects

NCT04839744 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Male Subjects

Interventions

DRUG: TG103 produced by the modified manufacturing process
DRUG: TG103 produced by the original manufacturing process

Sponsor

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.